Warning! GuruFocus detected
4 Severe warning signs
with HBC.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Hofseth BioCare ASA
NAICS : 325412
SIC : 2834
ISIN : NO0010598683
Description
Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium, and nonwater soluble protein. The brands under the company are OmeGo, PetGo, ProGo, and CalGo. The firm sells products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | 0.18 | |||||
| Debt-to-Equity | 2.76 | |||||
| Debt-to-EBITDA | -2.52 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.51 | |||||
| Beneish M-Score | -3.92 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 36.6 | |||||
| 3-Year EBITDA Growth Rate | 12.3 | |||||
| 3-Year EPS without NRI Growth Rate | 2.9 | |||||
| 3-Year FCF Growth Rate | 50.4 | |||||
| 3-Year Book Growth Rate | -27.4 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 11.21 | |||||
| 9-Day RSI | 22.94 | |||||
| 14-Day RSI | 31.12 | |||||
| 3-1 Month Momentum % | 34.24 | |||||
| 6-1 Month Momentum % | 61.97 | |||||
| 12-1 Month Momentum % | 19.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.67 | |||||
| Quick Ratio | 0.33 | |||||
| Cash Ratio | 0.15 | |||||
| Days Inventory | 154.1 | |||||
| Days Sales Outstanding | 32.02 | |||||
| Days Payable | 149.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.7 | |||||
| Shareholder Yield % | -2.83 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.13 | |||||
| Operating Margin % | -43.98 | |||||
| Net Margin % | -47.94 | |||||
| FCF Margin % | -18.6 | |||||
| ROE % | -122.87 | |||||
| ROA % | -32.94 | |||||
| ROIC % | -32.04 | |||||
| 3-Year ROIIC % | 14.98 | |||||
| ROC (Joel Greenblatt) % | -59.73 | |||||
| ROCE % | -54.66 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.63 | |||||
| PB Ratio | 15.03 | |||||
| Price-to-Tangible-Book | 40 | |||||
| EV-to-EBIT | -8.98 | |||||
| EV-to-EBITDA | -14.23 | |||||
| EV-to-Revenue | 3.76 | |||||
| EV-to-FCF | -22.52 | |||||
| Price-to-GF-Value | 0.4 | |||||
| Price-to-Median-PS-Value | 0.35 | |||||
| Earnings Yield (Greenblatt) % | -11.14 | |||||
| FCF Yield % | -5.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hofseth BioCare ASA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 257.417 | ||
| EPS (TTM) (kr) | -0.3 | ||
| Beta | 0.96 | ||
| 3-Year Sharpe Ratio | -0.15 | ||
| 3-Year Sortino Ratio | -0.32 | ||
| Volatility % | 97.6 | ||
| 14-Day RSI | 31.12 | ||
| 14-Day ATR (kr) | 0.215938 | ||
| 20-Day SMA (kr) | 2.3115 | ||
| 12-1 Month Momentum % | 19.32 | ||
| 52-Week Range (kr) | 1.16 - 3.6 | ||
| Shares Outstanding (Mil) | 411.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hofseth BioCare ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hofseth BioCare ASA Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hofseth BioCare ASA Frequently Asked Questions
What is Hofseth BioCare ASA(OSL:HBC)'s stock price today?
The current price of OSL:HBC is kr2.00. The 52 week high of OSL:HBC is kr3.60 and 52 week low is kr1.16.
When is next earnings date of Hofseth BioCare ASA(OSL:HBC)?
The next earnings date of Hofseth BioCare ASA(OSL:HBC) is 2025-05-16.
Does Hofseth BioCare ASA(OSL:HBC) pay dividends? If so, how much?
Hofseth BioCare ASA(OSL:HBC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers